SOPHiA Genetics SA
€4.22
0
-€0.06-1.4% 今天
统计数据
当日最高
4.22
当日最低
4.22
52周最高
-
52周最低
-
成交量
0
平均成交量
-
市值
-
市盈率
-
股息收益率
-
股息
-
收益
7May已确认
预期每股收益
-0.2285997
实际每股收益
N/A
人们还关注
此列表基于关注90B.F的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
Illumina
ILMN
市值18.49B
Pacific Biosciences of California
PACB
市值457.56M
Guardant Health
GH
市值3.52B
Fulgent Genetics
FLGT
市值626.91M
Qiagen NV
QGEN
市值9.38B
Bionano Genomics
BNGO
市值43.75M
Exact Sciences
EXAS
市值8.55B
Thermo Fisher Scientific
TMO
市值209.21B
Intellia Therapeutics
NTLA
市值2.49B
关于
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Show more...
首席执行官
员工
430
国家
CH
ISIN
CH1125843347
WKN
000A3CVT8